-
1دورية أكاديمية
المؤلفون: O'Shaughnessy, Joyce, Brufsky, Adam, Rugo, Hope S, Tolaney, Sara M, Punie, Kevin, Sardesai, Sagar, Hamilton, Erika, Loirat, Delphine, Traina, Tiffany, Leon-Ferre, Roberto, Hurvitz, Sara A, Kalinsky, Kevin, Bardia, Aditya, Henry, Stéphanie, Mayer, Ingrid, Zhu, Yanni, Phan, See, Cortés, Javier
المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale
المصدر: Breast cancer research and treatment, Vol. 195, no. 2, p. 127-139 (2022)
مصطلحات موضوعية: Antibody–drug conjugate, Cyclin-dependent kinase inhibitor, Sacituzumab govitecan
العلاقة: boreal:260771; http://hdl.handle.net/2078.1/260771Test; info:pmid/35545724; urn:ISSN:0167-6806; urn:EISSN:1573-7217
-
2دورية أكاديمية
المؤلفون: O'Shaughnessy, Joyce, Brufsky, Adam, Rugo, Hope S, Tolaney, Sara M, Punie, Kevin, Sardesai, Sagar, Hamilton, Erika, Loirat, Delphine, Traina, Tiffany, Leon-Ferre, Roberto, Hurvitz, Sara A, Kalinsky, Kevin, Bardia, Aditya, Henry, Stéphanie, Mayer, Ingrid, Zhu, Yanni, Phan, See, Cortés, Javier
المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale
المصدر: Breast cancer research and treatment, Vol. 195, no. 2, p. 127-139 (2022)
مصطلحات موضوعية: Antibody–drug conjugate, Cyclin-dependent kinase inhibitor, Sacituzumab govitecan
العلاقة: boreal:260771; http://hdl.handle.net/2078.1/260771Test; info:pmid/35545724; urn:ISSN:0167-6806; urn:EISSN:1573-7217